Literature DB >> 35305247

Bacteriophage therapy in aquaculture: current status and future challenges.

Ruyin Liu1,2,3, Ganghua Han4,5,6, Zong Li4,5,6, Shujuan Cun4,5,6, Bin Hao7,8, Jianping Zhang9, Xinchun Liu10,11.   

Abstract

The escalation of antibiotic resistance has revitalized bacteriophage (phage) therapy. Recently, phage therapy has been gradually applied in medicine, agriculture, food, and environmental fields due to its distinctive features of high efficiency, specificity, and environmental friendliness compared to antibiotics. Likewise, phage therapy also holds great promise in controlling pathogenic bacteria in aquaculture. The application of phage therapy instead of antibiotics to eliminate pathogenic bacteria such as Vibrio, Pseudomonas, Aeromonas, and Flavobacterium and to reduce fish mortality in aquaculture has been frequently reported. In this context, the present review summarizes and analyzes the current status of phage therapy in aquaculture, focusing on the key parameters of phage application, such as phage isolation, selection, dosage, and administration modes, and introducing the strategies and methods to boost efficacy and restrain the emergence of resistance. In addition, we discussed the human safety, environmental friendliness, and techno-economic practicability of phage therapy in aquaculture. Finally, this review outlines the current challenges of phage therapy application in aquaculture from the perspectives of phage resistance, phage-mediated resistance gene transfer, and effects on the host immune system.
© 2022. Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i.

Entities:  

Keywords:  Aquaculture; Efficacy; Phage resistance; Phage therapy

Mesh:

Substances:

Year:  2022        PMID: 35305247     DOI: 10.1007/s12223-022-00965-6

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  115 in total

Review 1.  Phage cocktails and the future of phage therapy.

Authors:  Benjamin K Chan; Stephen T Abedon; Catherine Loc-Carrillo
Journal:  Future Microbiol       Date:  2013-06       Impact factor: 3.165

Review 2.  Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.

Authors:  Yves Briers; Rob Lavigne
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 3.  Bacteriophages as Environmental Reservoirs of Antibiotic Resistance.

Authors:  William Calero-Cáceres; Mao Ye; José Luis Balcázar
Journal:  Trends Microbiol       Date:  2019-03-21       Impact factor: 17.079

4.  Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance.

Authors:  Joshua M Borin; Sarit Avrani; Jeffrey E Barrick; Katherine L Petrie; Justin R Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-08       Impact factor: 11.205

5.  Coupled virus - bacteria interactions and ecosystem function in an engineered microbial system.

Authors:  M R Brown; J C Baptista; M Lunn; D L Swan; S J Smith; R J Davenport; B D Allen; W T Sloan; T P Curtis
Journal:  Water Res       Date:  2019-01-11       Impact factor: 11.236

Review 6.  The pan-immune system of bacteria: antiviral defence as a community resource.

Authors:  Aude Bernheim; Rotem Sorek
Journal:  Nat Rev Microbiol       Date:  2019-11-06       Impact factor: 60.633

7.  Morphologic and genomic characterization of a broad host range Salmonella enterica serovar Pullorum lytic phage vB_SPuM_SP116.

Authors:  Hongduo Bao; Khashayar Shahin; Qiaoyan Zhang; Hui Zhang; Zhen Wang; Yan Zhou; Xuhui Zhang; Shujiao Zhu; Schmidt Stefan; Ran Wang
Journal:  Microb Pathog       Date:  2019-08-06       Impact factor: 3.738

Review 8.  Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants.

Authors:  Adelaide Almeida; Angela Cunha; Newton C M Gomes; Eliana Alves; Liliana Costa; Maria A F Faustino
Journal:  Mar Drugs       Date:  2009-07-30       Impact factor: 5.118

9.  Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.

Authors:  Marco Cafora; Gianluca Deflorian; Francesca Forti; Laura Ferrari; Giorgio Binelli; Federica Briani; Daniela Ghisotti; Anna Pistocchi
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

10.  Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa.

Authors:  Benjamin K Chan; Mark Sistrom; John E Wertz; Kaitlyn E Kortright; Deepak Narayan; Paul E Turner
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  2 in total

Review 1.  Phage Products for Fighting Antimicrobial Resistance.

Authors:  Yuanling Huang; Wenhui Wang; Zhihao Zhang; Yufeng Gu; Anxiong Huang; Junhao Wang; Haihong Hao
Journal:  Microorganisms       Date:  2022-06-30

2.  Characterization and Genomic Analysis of Novel Vibrio parahaemolyticus Phage vB_VpaP_DE10.

Authors:  Yuanming Ye; Hanfang Chen; Qiaolan Huang; Shixuan Huang; Jiaxin He; Jumei Zhang; Qingping Wu; Xueling Li; Wenfeng Hu; Meiyan Yang
Journal:  Viruses       Date:  2022-07-23       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.